Navigation Links
Revolutionary, Minimally Invasive Treatment Provides Long-lasting Chronic Sinusitis Relief
Date:3/18/2009

Saint Joseph Hospital Among the First to Offer New Surgical Treatment Approach

CHICAGO, March 18 /PRNewswire/ -- After three years of suffering from congestion and several months of trying a steroid nasal spray, Chicago resident Matt Minella, 31, opted for a surgical procedure to help him breathe better through his nose.

Within days of the procedure, Minella was back to work and running again thanks to a new endoscopic balloon device called the Relieva Stratus(TM) Microflow Spacer. The device is the first endoscopic instrument to release medication directly into the sinuses over a two- to three-week period.

Saint Joseph Hospital is offering this new treatment approach for patients who suffer from chronic sinusitis, an inflammation of the sinus lining caused by bacterial, viral and/or microbial infections, as well as structural issues like sinus opening blockages. If the sinus opening is closed, normal mucus drainage may not occur, leading to infection and inflammation of the sinuses.

"I am not only breathing better, but sleeping and talking better," said Minella, a marathon runner and exercise enthusiast. "The treatment is a no-brainer for anyone living with sinus problems."

The outpatient procedure involves using flexible, thin balloon catheters to enlarge sinus openings. The doctor places the device in one or both nostrils, which inflates inside the sinus. Medication slowly releases from the balloon's micro-pores, bathing the sinus lining, decreasing inflammation and opening nasal passages to drain excess fluid. The device is removed 14 to 21 days after surgery.

"Following surgery, the medication continues to treat symptoms of sinusitis without the patients even feeling the implanted device - helping them to recover sooner," said Jordan Pritikin, M.D., chief of the Section of Otolaryngology, Saint Joseph Hospital.

"Historically, sinusitis patients have been limited to either sinus surgery or medical therapy, such as antibiotics, decongestants and steroid nasal sprays," said Dr. Pritikin, who is one of the first otolaryngologists - ear, nose and throat specialists - in Chicago and Illinois to use the new device.

With the new device, there is no need for tissue or bone removal. That means minimal discomfort, almost no bleeding and shortened recovery time. Most patients are able to return to normal activities within two to seven days.

Visit http://www.reshealth.org/aboutus/newsroom/press_release.cfm?pressReleaseID=1355.

Founded in 1868, Saint Joseph Hospital is part of Resurrection Health Care, a family of health care services providing advanced medical care and exceptional customer service with compassion and hope.


'/>"/>
SOURCE Saint Joseph Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Ajrawats Air-Pulse Autonomic Meditation Therapy, a Revolutionary, Scientific, Meditation Therapy, Receives Patent Trademark
2. Minimally Invasive Heart Surgery Research Wins N.I.H. Award
3. Novadaq launches PINPOINT: Companys first minimally invasive imaging system
4. Published Results Using AtriCure Minimally Invasive Products
5. Awake the Movie Highlights the Need for Goldilocks Anesthesia, Says Dr. Barry L. Friedberg, Developer of Bispectral Index (BIS) Monitored Propofol Ketamine Sedation, Now Trademarked as Minimally Invasive Anesthesia (MIA)(R)
6. Z-shaped incision enhances minimally-invasive surgery
7. Z-shaped incision enhances minimally invasive surgery
8. Minimally Invasive Surgery Fixes Aneurysms
9. Northwestern Memorials Heart Center Pioneers Minimally Invasive Surgery That Corrects Irregular Heart Beat
10. Minimally invasive fibroid treatment fares well in multicenter trial
11. Women Can Now Learn About Minimally Invasive Gynecologic Treatments at AAGL.org
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... serving San Francisco and environs, is proud to announce an upgrade to the ... on the upgraded Yelp page on topics as diverse as Platelet Rich Plasma ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based ... and Palo Alto, is proud to announce an important upgrade to its geographic information ... home care close to home, and by having city-specific pages, NuevaCare is answering that ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 2017 , ... Only two months after the official release of The Private ... (France), XO Private has initiated a second print-run of its lavish luxury travel coffee ... across when open, weighs in at more than six kilos, retails at EUR 1,000 ...
(Date:2/24/2017)... ... ... In the Health Care IT campaign, Robert Herjavec discusses health IT security ... will be attacked, but when.” However, he and many others involved highlight a promising ... in auditing and monitoring have taken security in health care a very long way. ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  Interpace Diagnostics Group, ... provides clinically useful molecular diagnostic tests and pathology services, ... presented at the upcoming United States ... held March 4-10, 2017 in San Antonio, ... a review of data from the Company,s extensive experience ...
(Date:2/27/2017)... Fla. , Feb. 27, 2017 ... focused on developing cerebral embolic protection devices for ... the FDA,s Circulatory System Devices Panel that convened ... need for cerebral protection following transcatheter aortic valve ... by this FDA panel support the need for ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
Breaking Medicine Technology: